A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

P. L. Amlot, M. J. Stone, D. Cunningham, J. Fay, J. Newman, R. Collins, R. May, M. McCarthy, J. Richardson, V. Ghetie, O. Ramilo, P. E. Thorpe, J. W. Uhr, E. S. Vitetta

Research output: Contribution to journalArticle

226 Scopus citations

Fingerprint Dive into the research topics of 'A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds